These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34299438)
21. Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals. Fügi MA; Wittlin S; Dong Y; Vennerstrom JL Antimicrob Agents Chemother; 2010 Mar; 54(3):1042-6. PubMed ID: 20028825 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin. Cloete TT; Wilma Breytenbach J; Kock Cd; Smith PJ; Breytenbach JC; N'da DD Bioorg Med Chem; 2012 Aug; 20(15):4701-9. PubMed ID: 22750008 [TBL] [Abstract][Full Text] [Related]
23. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702 [No Abstract] [Full Text] [Related]
24. Artemisone--a highly active antimalarial drug of the artemisinin class. Haynes RK; Fugmann B; Stetter J; Rieckmann K; Heilmann HD; Chan HW; Cheung MK; Lam WL; Wong HN; Croft SL; Vivas L; Rattray L; Stewart L; Peters W; Robinson BL; Edstein MD; Kotecka B; Kyle DE; Beckermann B; Gerisch M; Radtke M; Schmuck G; Steinke W; Wollborn U; Schmeer K; Römer A Angew Chem Int Ed Engl; 2006 Mar; 45(13):2082-8. PubMed ID: 16444785 [No Abstract] [Full Text] [Related]
25. Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin. Park GM; Park H; Oh S; Lee S Korean J Parasitol; 2017 Dec; 55(6):661-665. PubMed ID: 29320822 [TBL] [Abstract][Full Text] [Related]
26. Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1. Singh C; Chaudhary S; Kanchan R; Puri SK Org Lett; 2007 Oct; 9(21):4327-9. PubMed ID: 17877363 [TBL] [Abstract][Full Text] [Related]
27. Biological actions of artemisinin: insights from medicinal chemistry studies. Li J; Zhou B Molecules; 2010 Mar; 15(3):1378-97. PubMed ID: 20335987 [TBL] [Abstract][Full Text] [Related]
29. Docking studies of structurally diverse antimalarial drugs targeting PfATP6: no correlation between in silico binding affinity and in vitro antimalarial activity. Garah FB; Stigliani JL; Coslédan F; Meunier B; Robert A ChemMedChem; 2009 Sep; 4(9):1469-79. PubMed ID: 19645001 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277). Uhlemann AC; Wittlin S; Matile H; Bustamante LY; Krishna S Antimicrob Agents Chemother; 2007 Feb; 51(2):667-72. PubMed ID: 17145800 [TBL] [Abstract][Full Text] [Related]
31. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action. Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071 [TBL] [Abstract][Full Text] [Related]
32. C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene. Ekthawatchai S; Kamchonwongpaisan S; Kongsaeree P; Tarnchompoo B; Thebtaranonth Y; Yuthavong Y J Med Chem; 2001 Dec; 44(26):4688-95. PubMed ID: 11741486 [TBL] [Abstract][Full Text] [Related]
33. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses. Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352 [TBL] [Abstract][Full Text] [Related]
34. Quantitative structure-activity relationships of the antimalarial agent artemisinin and some of its derivatives - a DFT approach. Rajkhowa S; Hussain I; Hazarika KK; Sarmah P; Deka RC Comb Chem High Throughput Screen; 2013 Sep; 16(8):590-602. PubMed ID: 23597248 [TBL] [Abstract][Full Text] [Related]
36. Antimalarial activity of 10-alkyl/aryl esters and -aminoethylethers of artemisinin. Cloete TT; Krebs HJ; Clark JA; Connelly MC; Orcutt A; Sigal MS; Guy RK; N'Da DD Bioorg Chem; 2013 Feb; 46():10-6. PubMed ID: 23247255 [TBL] [Abstract][Full Text] [Related]
37. Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate. Magueur G; Crousse B; Charneau S; Grellier P; Bégué JP; Bonnet-Delpon D J Med Chem; 2004 May; 47(10):2694-9. PubMed ID: 15115411 [TBL] [Abstract][Full Text] [Related]
38. Antimalarial activity of new dihydroartemisinin derivatives. 6. alpha-Alkylbenzylic ethers. Lin AJ; Miller RE J Med Chem; 1995 Mar; 38(5):764-70. PubMed ID: 7877142 [TBL] [Abstract][Full Text] [Related]
39. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials. Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900 [TBL] [Abstract][Full Text] [Related]
40. Heme as trigger and target for trioxane-containing antimalarial drugs. Meunier B; Robert A Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]